These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Risk factors for recurrent events in subjects with superficial vein thrombosis in the randomized clinical trial SteFlux (Superficial Thromboembolism Fluxum). Cosmi B; Filippini M; Campana F; Avruscio G; Ghirarduzzi A; Bucherini E; Camporese G; Imberti D; Legnani C; Palareti G; Thromb Res; 2014 Feb; 133(2):196-202. PubMed ID: 24365043 [TBL] [Abstract][Full Text] [Related]
25. Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end points. Turpie AG; Bauer KA; Eriksson BI; Lassen MR Chest; 2004 Aug; 126(2):501-8. PubMed ID: 15302737 [TBL] [Abstract][Full Text] [Related]
26. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial. Righini M; Galanaud JP; Guenneguez H; Brisot D; Diard A; Faisse P; Barrellier MT; Hamel-Desnos C; Jurus C; Pichot O; Martin M; Mazzolai L; Choquenet C; Accassat S; Robert-Ebadi H; Carrier M; Le Gal G; Mermilllod B; Laroche JP; Bounameaux H; Perrier A; Kahn SR; Quere I Lancet Haematol; 2016 Dec; 3(12):e556-e562. PubMed ID: 27836513 [TBL] [Abstract][Full Text] [Related]
27. Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Turpie AG; Bauer KA; Eriksson BI; Lassen MR Arch Intern Med; 2002 Sep; 162(16):1833-40. PubMed ID: 12196081 [TBL] [Abstract][Full Text] [Related]
28. Treatment of superficial vein thrombosis to prevent deep vein thrombosis and pulmonary embolism: a systematic review. Wichers IM; Di Nisio M; Büller HR; Middeldorp S Haematologica; 2005 May; 90(5):672-7. PubMed ID: 15921382 [TBL] [Abstract][Full Text] [Related]
29. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin. Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321 [TBL] [Abstract][Full Text] [Related]
30. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. Büller HR; Davidson BL; Decousus H; Gallus A; Gent M; Piovella F; Prins MH; Raskob G; Segers AE; Cariou R; Leeuwenkamp O; Lensing AW; Ann Intern Med; 2004 Jun; 140(11):867-73. PubMed ID: 15172900 [TBL] [Abstract][Full Text] [Related]
31. Impact of emergency department management of isolated superficial vein thrombosis of the lower limbs: a secondary analysis of data from the ALTAMIRA study. Beddar Chaib F; Jiménez Hernández S; Pedrajas Navas JM; Lecumberri R; Guirado Torrecillas L; Alonso Valle H; Diego Roza S; Sendín Martín V; Rivera Núñez MA; Pedraza García J; Sánchez Díaz-Canel D; Ruiz Artacho P; Emergencias; 2023 Apr; 35(2):109-116. PubMed ID: 37038941 [TBL] [Abstract][Full Text] [Related]
32. [General medicine management of superficial venous thrombosis of the lower limbs: A survey in Saône-et-Loire]. Cartal C; Bertoletti L; Décousus H; Frappe P J Mal Vasc; 2016 Feb; 41(1):12-7. PubMed ID: 26631922 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. Cohen AT; Davidson BL; Gallus AS; Lassen MR; Prins MH; Tomkowski W; Turpie AG; Egberts JF; Lensing AW; BMJ; 2006 Feb; 332(7537):325-9. PubMed ID: 16439370 [TBL] [Abstract][Full Text] [Related]
34. Spontaneous acute superficial vein thrombosis of the legs: do we really need to treat? Décousus H; Bertoletti L; Frappé P J Thromb Haemost; 2015 Jun; 13 Suppl 1():S230-7. PubMed ID: 26149029 [TBL] [Abstract][Full Text] [Related]
35. Fondaparinux sodium: a review of its use in the treatment of acute venous thromboembolism. Robinson DM; Wellington K Am J Cardiovasc Drugs; 2005; 5(5):335-46. PubMed ID: 16156690 [TBL] [Abstract][Full Text] [Related]
36. A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis. Superficial Thrombophlebitis Treated By Enoxaparin Study Group Arch Intern Med; 2003 Jul; 163(14):1657-63. PubMed ID: 12885680 [TBL] [Abstract][Full Text] [Related]
37. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study. Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643 [TBL] [Abstract][Full Text] [Related]
38. [Superficial vein thrombosis: what's new in the management?]. Gencer B; Tribout B; Alatri A; Mazzolai L; Calanca L Rev Med Suisse; 2011 Oct; 7(314):2098-101. PubMed ID: 22141309 [TBL] [Abstract][Full Text] [Related]
39. Fondaparinux: an update on new study results. Bauersachs RM Eur J Clin Invest; 2005 Mar; 35 Suppl 1():27-32. PubMed ID: 15701145 [TBL] [Abstract][Full Text] [Related]